Figure 4.
Effect of CMC-544 on developing or large Ramos BCL xenografts. Effect of CMC-544 on developing (A) or large established Ramos BCL xenografts (B). CMA-676 was used as a nonbinding control conjugate. Doses are shown in CalichDMH equivalents. Results are presented as mean tumor mass ± SEM.